In the pancreatic tumor microenvironment, KRAS mutant cancer cells induced the expression of GLI1 in surrounding fibroblasts, followed by the binding of GLI1 to the cytokine interleukin (IL)-6 promoter inducing its expression [64]. This evidence concerns the gene KRAS and cancer.